[1]
De Filippo, M. et al. 2022. Omalizumab and allergen immunotherapy for respiratory allergies: A mini-review from the Allergen-Immunotherapy Committee of the Italian Society of Pediatric Allergy and Immunology (SIAIP). Allergologia et Immunopathologia. 50, 6 (Nov. 2022), 47–52. DOI:https://doi.org/10.15586/aei.v50i6.495.